Adding peginterferon alfa-2a to entecavir increases HBsAg decline and HBeAg clearance - first results from a global randomized trial (ARES study)
Author
Xie, Qing
Zhang, Qin
Sonneveld, Milan J.
Zhang, Ning-Ping
Tabak, Fehmi
Janssen, Harry L.
Hansen, Bettina E.
Verhey, Elke
van Vuuren, Anneke J.
Diculescu, Mircea.
de Niet, Annikki
İDİLMAN, RAMAZAN
Wang, Jiyao
Streinu-cercel, Adrian
Metadata
Show full item recordCollections
- Bildiri [64839]